A deep-learning reactive force field from Beijing-based MoleculeMind has become the first AI platform peer-reviewed for simulating an enzyme's complete catalytic cycle — including proton transfer, ...

Generating drug candidates with AI has advanced rapidly. Generative models can now design protein backbones, propose binding molecules, and optimize sequences for target properties at speeds no human ...